Markus Kalousek
PhD, Chair
Dr. Markus Kalousek, Chairman of FimmCyte, brings over 25 years of pharma experience to the company. With a PhD in Oncology and Cancer Biology from ETH Zürich and nearly two decades at Novartis, latest as VP Partnering. Dr. Kalousek’s expertise spans R&D, business development, and drug innovation. His leadership at FimmCyte is instrumental in advancing the company’s goals in women’s health.
His extensive background in both biotech and large pharma, including roles at CSL and Novartis, Dr. Kalousek’s strategic insights and proven track record in developing innovative drugs are pivotal to FimmCyte’s efforts to address this underserved area of medical need.
